과제정보
This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF-2022R1A2B5B02001854) and a Korea University Grant.
참고문헌
- Aggarwal, V., Tuli, H.S., Varol, A., Thakral, F., Yerer, M.B., Sak, K., Varol, M., Jain, A., Khan, M.A., and Sethi, G. (2019). Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements. Biomolecules 9, 735.
- Antalis, T.M., Buzza, M.S., Hodge, K.M., Hooper, J.D., and Netzel-Arnett, S. (2010). The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment. Biochem. J. 428, 325-346. https://doi.org/10.1042/BJ20100046
- Aslakson, C.J. and Miller, F.R. (1992). Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 52, 1399-1405.
- Benaud, C., Dickson, R.B., and Lin, C.Y. (2001). Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor. Eur. J. Biochem. 268, 1439-1447. https://doi.org/10.1046/j.1432-1327.2001.02016.x
- Benaud, C., Oberst, M., Hobson, J.P., Spiegel, S., Dickson, R.B., and Lin, C.Y. (2002). Sphingosine 1-phosphate, present in serum-derived lipoproteins, activates matriptase. J. Biol. Chem. 277, 10539-10546. https://doi.org/10.1074/jbc.M109064200
- Bonapace, L., Coissieux, M.M., Wyckoff, J., Mertz, K.D., Varga, Z., Junt, T., and Bentires-Alj, M. (2014). Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis. Nature 515, 130-133. https://doi.org/10.1038/nature13862
- Brill, A., Chauhan, A.K., Canault, M., Walsh, M.T., Bergmeier, W., and Wagner, D.D. (2009). Oxidative stress activates ADAM17/TACE and induces its target receptor shedding in platelets in a p38-dependent fashion. Cardiovasc. Res. 84, 137-144. https://doi.org/10.1093/cvr/cvp176
- Chae, D.S., Han, S., Lee, M.K., and Kim, S.W. (2021). Genome edited Sirt1-Overexpressing human mesenchymal stem cells exhibit therapeutic effects in treating collagen-induced arthritis. Mol. Cells 44, 245-253. https://doi.org/10.14348/molcells.2021.0037
- Cho, E.G., Kim, M.G., Kim, C., Kim, S.R., Seong, I.S., Chung, C., Schwartz, R.H., and Park, D. (2001). N-terminal processing is essential for release of epithin, a mouse type II membrane serine protease. J. Biol. Chem. 276, 44581-44589. https://doi.org/10.1074/jbc.M107059200
- Cho, E.G., Schwartz, R.H., and Kim, M.G. (2005). Shedding of membrane epithin is blocked without LDLRA4 and its protease activation site. Biochem. Biophys. Res. Commun. 327, 328-334. https://doi.org/10.1016/j.bbrc.2004.12.014
- Cho, Y., Kim, S.B., Kim, J., Pham, A.V.Q., Yoon, M.J., Park, J.H., Hwang, K.T., Park, D., Cho, Y., Kim, M.G., et al. (2020). Intramembrane proteolysis of an extracellular serine protease, epithin/PRSS14, enables its intracellular nuclear function. BMC Biol. 18, 60.
- Cho, Y., Park, D., and Kim, C. (2017). Disruption of TACE-filamin interaction can inhibit TACE-mediated ectodomain shedding. Biochem. Biophys. Res. Commun. 490, 997-1003. https://doi.org/10.1016/j.bbrc.2017.06.153
- Ha, S.Y., Kim, K.Y., Lee, N.K., Kim, M.G., and Kim, S.H. (2014). Overexpression of matriptase correlates with poor prognosis in esophageal squamous cell carcinoma. Virchows Arch. 464, 19-27. https://doi.org/10.1007/s00428-013-1504-3
- Ihara, S., Miyoshi, E., Ko, J.H., Murata, K., Nakahara, S., Honke, K., Dickson, R.B., Lin, C.Y., and Taniguchi, N. (2002). Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1-6 GlcNAc branching. J. Biol. Chem. 277, 16960-16967. https://doi.org/10.1074/jbc.M200673200
- Jin, X., Yagi, M., Akiyama, N., Hirosaki, T., Higashi, S., Lin, C.Y., Dickson, R.B., Kitamura, H., and Miyazaki, K. (2006). Matriptase activates stromelysin (MMP-3) and promotes tumor growth and angiogenesis. Cancer Sci. 97, 1327-1334. https://doi.org/10.1111/j.1349-7006.2006.00328.x
- Kang, J.Y., Dolled-Filhart, M., Ocal, I.T., Singh, B., Lin, C.Y., Dickson, R.B., Rimm, D.L., and Camp, R.L. (2003). Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer. Cancer Res. 63, 1101-1105.
- Kim, C., Cho, Y., Kang, C.H., Kim, M.G., Lee, H., Cho, E.G., and Park, D. (2005). Filamin is essential for shedding of the transmembrane serine protease, epithin. EMBO Rep. 6, 1045-1051. https://doi.org/10.1038/sj.embor.7400534
- Kim, C., Lee, H.S., Lee, D., Lee, S.D., Cho, E.G., Yang, S.J., Kim, S.B., Park, D., and Kim, M.G. (2011). Epithin/PRSS14 proteolytically regulates angiopoietin receptor Tie2 during transendothelial migration. Blood 117, 1415-1424. https://doi.org/10.1182/blood-2010-03-275289
- Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., and Salzberg, S.L. (2013). TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36.
- Kim, K.Y., Lee, G., Yoon, M., Cho, E.H., Park, C.S., and Kim, M.G. (2015). Expression analyses revealed thymic stromal co-transporter/Slc46A2 is in stem cell populations and is a putative tumor suppressor. Mol. Cells 38, 548-561. https://doi.org/10.14348/molcells.2015.0044
- Kim, M.G., Chen, C., Lyu, M.S., Cho, E.G., Park, D., Kozak, C., and Schwartz, R.H. (1999). Cloning and chromosomal mapping of a gene isolated from thymic stromal cells encoding a new mouse type II membrane serine protease, epithin, containing four LDL receptor modules and two CUB domains. Immunogenetics 49, 420-428. https://doi.org/10.1007/s002510050515
- Kim, S., Yang, J.W., Kim, C., and Kim, M.G. (2016). Impact of suppression of tumorigenicity 14 (ST14)/serine protease 14 (Prss14) expression analysis on the prognosis and management of estrogen receptor negative breast cancer. Oncotarget 7, 34643-34663. https://doi.org/10.18632/oncotarget.9155
- Kim, S.B., Lee, D., Jeong, J.W., Kim, C., Park, D., and Kim, M.G. (2010). Soluble epithin/PRSS14 secreted from cancer cells contains active angiogenic potential. Mol. Cells 29, 617-623. https://doi.org/10.1007/s10059-010-0077-0
- Ko, C.J., Lan, S.W., Lu, Y.C., Cheng, T.S., Lai, P.F., Tsai, C.H., Hsu, T.W., Lin, H.Y., Shyu, H.Y., Wu, S.R., et al. (2017). Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis. Oncogene 36, 4597-4609. https://doi.org/10.1038/onc.2017.82
- Kuhnle, N., Dederer, V., and Lemberg, M.K. (2019). Intramembrane proteolysis at a glance: from signalling to protein degradation. J. Cell Sci. 132, jcs217745.
- Kursvietiene, L., Mongirdiene, A., Bernatoniene, J., Sulinskiene, J., and Staneviciene, I. (2020). Selenium anticancer properties and impact on cellular redox status. Antioxidants (Basel) 9, 80.
- Lal, M. and Caplan, M. (2011). Regulated intramembrane proteolysis: signaling pathways and biological functions. Physiology (Bethesda) 26, 34-44.
- Lee, H.S., Park, B.M., Cho, Y., Kim, S., Kim, C., Kim, M.G., and Park, D. (2014). Shedding of epithin/PRSS14 is induced by TGF-beta and mediated by tumor necrosis factor-alpha converting enzyme. Biochem. Biophys. Res. Commun. 452, 1084-1090. https://doi.org/10.1016/j.bbrc.2014.09.055
- Levitin, F., Stern, O., Weiss, M., Gil-Henn, C., Ziv, R., Prokocimer, Z., Smorodinsky, N.I., Rubinstein, D.B., and Wreschner, D.H. (2005). The MUC1 SEA module is a self-cleaving domain. J. Biol. Chem. 280, 33374-33386. https://doi.org/10.1074/jbc.M506047200
- Liao, Z., Chua, D., and Tan, N.S. (2019). Reactive oxygen species: a volatile driver of field cancerization and metastasis. Mol. Cancer 18, 65.
- List, K., Szabo, R., Molinolo, A., Sriuranpong, V., Redeye, V., Murdock, T., Burke, B., Nielsen, B.S., Gutkind, J.S., and Bugge, T.H. (2005). Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation. Genes Dev. 19, 1934-1950. https://doi.org/10.1101/gad.1300705
- Mantovani, A., Barajon, I., and Garlanda, C. (2018). IL-1 and IL-1 regulatory pathways in cancer progression and therapy. Immunol. Rev. 281, 57-61. https://doi.org/10.1111/imr.12614
- Mao, Z., Zhang, J., Shi, Y., Li, W., Shi, H., Ji, R., Mao, F., Qian, H., Xu, W., and Zhang, X. (2020). CXCL5 promotes gastric cancer metastasis by inducing epithelial-mesenchymal transition and activating neutrophils. Oncogenesis 9, 63.
- Martin, C.E. and List, K. (2019). Cell surface-anchored serine proteases in cancer progression and metastasis. Cancer Metastasis Rev. 38, 357-387. https://doi.org/10.1007/s10555-019-09811-7
- Oberst, M., Anders, J., Xie, B., Singh, B., Ossandon, M., Johnson, M., Dickson, R.B., and Lin, C.Y. (2001). Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. Am. J. Pathol. 158, 1301-1311. https://doi.org/10.1016/S0002-9440(10)64081-3
- Oberst, M.D., Johnson, M.D., Dickson, R.B., Lin, C.Y., Singh, B., Stewart, M., Williams, A., al-Nafussi, A., Smyth, J.F., Gabra, H., et al. (2002). Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters. Clin. Cancer Res. 8, 1101-1107.
- Pastushenko, I. and Blanpain, C. (2019). EMT transition states during tumor progression and metastasis. Trends Cell Biol. 29, 212-226. https://doi.org/10.1016/j.tcb.2018.12.001
- Rayman, M.P. (2000). The importance of selenium to human health. Lancet 356, 233-241. https://doi.org/10.1016/S0140-6736(00)02490-9
- Saleem, M., Adhami, V.M., Zhong, W., Longley, B.J., Lin, C.Y., Dickson, R.B., Reagan-Shaw, S., Jarrard, D.F., and Mukhtar, H. (2006). A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1. Cancer Epidemiol. Biomarkers Prev. 15, 217-227. https://doi.org/10.1158/1055-9965.EPI-05-0737
- Sales, K.U., Friis, S., Konkel, J.E., Godiksen, S., Hatakeyama, M., Hansen, K.K., Rogatto, S.R., Szabo, R., Vogel, L.K., Chen, W., et al. (2015). Non-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesis. Oncogene 34, 346-356. https://doi.org/10.1038/onc.2013.563
- Szatrowski, T.P. and Nathan, C.F. (1991). Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51, 794-798.
- Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D.R., Pimentel, H., Salzberg, S.L., Rinn, J.L., and Pachter, L. (2012). Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7, 562-578. https://doi.org/10.1038/nprot.2012.016
- Tsai, C.H., Teng, C.H., Tu, Y.T., Cheng, T.S., Wu, S.R., Ko, C.J., Shyu, H.Y., Lan, S.W., Huang, H.P., Tzeng, S.F., et al. (2014). HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase. Oncogene 33, 4643-4652. https://doi.org/10.1038/onc.2013.412
- Tseng, C.C., Jia, B., Barndt, R., Gu, Y., Chen, C.Y., Tseng, I.C., Su, S.F., Wang, J.K., Johnson, M.D., and Lin, C.Y. (2017). Matriptase shedding is closely coupled with matriptase zymogen activation and requires de novo proteolytic cleavage likely involving its own activity. PLoS One 12, e0183507.
- Wang, J.K., Teng, I.J., Lo, T.J., Moore, S., Yeo, Y.H., Teng, Y.C., Kaul, M., Chen, C.C., Zuo, A.H., Chou, F.P., et al. (2014). Matriptase autoactivation is tightly regulated by the cellular chemical environments. PLoS One 9, e93899.
- Wei, T., Simk, V., Levy, M., Xie, Y., Jin, Y., and Zemla, J. (2017). R package "corrplot": Visualization of a Correlation Matrix (Version 0.84).
- Yoshimura, T., Howard, O.M., Ito, T., Kuwabara, M., Matsukawa, A., Chen, K., Liu, Y., Liu, M., Oppenheim, J.J., and Wang, J.M. (2013). Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells. PLoS One8 , e58791.
- Zoratti, G.L., Tanabe, L.M., Varela, F.A., Murray, A.S., Bergum, C., Colombo, E., Lang, J.E., Molinolo, A.A., Leduc, R., Marsault, E., et al. (2015). Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling. Nat. Commun. 6, 6776.